Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2620272rdf:typepubmed:Citationlld:pubmed
pubmed-article:2620272lifeskim:mentionsumls-concept:C0023487lld:lifeskim
pubmed-article:2620272lifeskim:mentionsumls-concept:C0040715lld:lifeskim
pubmed-article:2620272pubmed:issue8lld:pubmed
pubmed-article:2620272pubmed:dateCreated1990-3-23lld:pubmed
pubmed-article:2620272pubmed:abstractTextCytogenetic studies using Giemsa R-bands after a short term culture of bone marrow or peripheral blood were done in 20 cases of acute promyelocytic leukemia (APL), including three cases of microgranular variant. As a result, t (15;17) cells were found in all the cells, and the percentages of the abnormal cells were 38-100%. In 2 cases, t(15;17) was seen in 88% and 65% of the cells in cultured specimens, whereas no such translocation was seen in direct specimens. Among 6 cases treated with tretinoin, 5 achieved complete remission, and among 14 cases treated by HOAP protocol 2 achieved complete remission. Reexamination of 4 of these cases during the stage of complete remission failed to find t(15;17). These data revealed that t(15;17) may probably be present in all cases of APL, and therefore is a very useful diagnostic criterion, especially in cases of micro granular APL. But the detection rate is determined by methodology, which requires special precaution.lld:pubmed
pubmed-article:2620272pubmed:languagechilld:pubmed
pubmed-article:2620272pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2620272pubmed:citationSubsetIMlld:pubmed
pubmed-article:2620272pubmed:statusMEDLINElld:pubmed
pubmed-article:2620272pubmed:monthAuglld:pubmed
pubmed-article:2620272pubmed:issn0376-2491lld:pubmed
pubmed-article:2620272pubmed:authorpubmed-author:XueY QYQlld:pubmed
pubmed-article:2620272pubmed:issnTypePrintlld:pubmed
pubmed-article:2620272pubmed:volume69lld:pubmed
pubmed-article:2620272pubmed:ownerNLMlld:pubmed
pubmed-article:2620272pubmed:authorsCompleteYlld:pubmed
pubmed-article:2620272pubmed:pagination434-7, 30lld:pubmed
pubmed-article:2620272pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:2620272pubmed:meshHeadingpubmed-meshheading:2620272-...lld:pubmed
pubmed-article:2620272pubmed:meshHeadingpubmed-meshheading:2620272-...lld:pubmed
pubmed-article:2620272pubmed:meshHeadingpubmed-meshheading:2620272-...lld:pubmed
pubmed-article:2620272pubmed:meshHeadingpubmed-meshheading:2620272-...lld:pubmed
pubmed-article:2620272pubmed:meshHeadingpubmed-meshheading:2620272-...lld:pubmed
pubmed-article:2620272pubmed:meshHeadingpubmed-meshheading:2620272-...lld:pubmed
pubmed-article:2620272pubmed:meshHeadingpubmed-meshheading:2620272-...lld:pubmed
pubmed-article:2620272pubmed:meshHeadingpubmed-meshheading:2620272-...lld:pubmed
pubmed-article:2620272pubmed:meshHeadingpubmed-meshheading:2620272-...lld:pubmed
pubmed-article:2620272pubmed:meshHeadingpubmed-meshheading:2620272-...lld:pubmed
pubmed-article:2620272pubmed:year1989lld:pubmed
pubmed-article:2620272pubmed:articleTitle[Acute promyelocytic leukemia and 15;17 chromosome translocation].lld:pubmed
pubmed-article:2620272pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:2620272pubmed:publicationTypeEnglish Abstractlld:pubmed